24 results on '"Babaei, Mohammad Hossein"'
Search Results
2. 177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer
3. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer
4. MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles
5. Comparison of 99mTc-labeled PR81 and its F(ab′)2 fragments as radioimmunoscintigraphy agents for breast cancer imaging
6. Breast tumor targeting with 99mTc-HYNIC-PR81 complex as a new biologic radiopharmaceutical
7. Novel and facile methods for the synthesis of DTPA-mono-amide: a new completely revised strategy in radiopharmaceutical chemistry
8. Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells
9. Preparation and biological evaluation of 177Lu conjugated PR81 for radioimmunotherapy of breast cancer
10. Comparison of 99mTc-labeled PR81 and its F(ab′)2 fragments as radioimmunoscintigraphy agents for breast cancer imaging
11. MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles
12. Synthesis and biodistribution studiesof 177Lu‐trastuzumab as a therapeutic agent in the breast cancer mice model
13. Novel and facile methods for the synthesis of DTPA-mono-amide: a new completely revised strategy in radiopharmaceutical chemistry
14. Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells
15. A New Approach to Solve an Extended Portfolio Selection Problem.
16. Preparation and biological evaluation of 177Lu conjugated PR81 for radioimmunotherapy of breast cancer
17. Synthesis and biodistribution studiesof 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model.
18. Radioiodine D Amino Acids Labeling of Rituximab, A New Method for Enhancing the Radiopharmaceutical Targeting and Biostability.
19. A NEW MONOCLONAL ANTIBODY RADIOPHARMACEUTICAL FOR RADIOIMMUNOSCINTIGRAPHY OF BREAST CANCER: DIRECT LABELING OF ANTIBODY AND ITS QUALITY CONTROL.
20. Synthesis and biodistribution studiesof 177Lutrastuzumab as a therapeutic agent in the breast cancer mice model
21. 177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer
22. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer
23. Breast tumor targeting with 99mTc-HYNIC-PR81 complex as a new biologic radiopharmaceutical
24. [99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.